SOURCE: Cutting Edge Information

Cutting Edge Information

February 16, 2011 12:11 ET

New Study Covering Pharmaceutical eMarketing Management Now Underway

RESEARCH TRIANGLE PARK, NC--(Marketwire - February 16, 2011) -  Business intelligence leader Cutting Edge Information is announcing the launch of a new study focusing on eMarketing efforts in the pharmaceutical, biotechnology and medical devices industries. The survey is available at

"Our goal with this research is to target the resources, strategies and tactics of leading eMarketing groups," said David Richardson, Research Team Leader at Cutting Edge Information. "We are really aiming to identify the tactics necessary to maximize eMarketing's impact."

The final report will allow companies the ability to:

  • Review social media strategies of top performers including timing, investment and performance measurement
  • Understand how top companies' approach social media in the absence of detailed FDA guidances
  • Gauge eMarketing staffing, spending and other resources against companies of all sizes
  • Examine how companies are developing and using mobile apps for both physicians and patients

Cutting Edge Information plans to delve deep into the topics most important to lifesciences executives. By exploring companies' eMarketing management tactics, resource allocations, supporting structures, inherent challenges and unique strategies, executives will have the ability to learn from industry best practices to fine tune their own efforts.

Study participants will receive complimentary study findings when the report is completed. To participate in Cutting Edge Information's study on eMarketing visit

An independent business research firm specializing in pharma/biotech product commercialization and development, Cutting Edge Information works with some of the top drug makers in the industry. Their methods highlight the free exchange of information and all collected data is blinded. Every survey respondent is considered a partner in their research.

Contact Information

  • For more information on this study, contact
    David Richardson
    Email Contact
    +1 919-433-0216